Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ghali

Showing results (241-250 of 441) with videos related to

Pageof 45
Sort By:
The Canadian Journal of Cardiology|April 2, 2004
Interinstitutional variation in the use of abciximab for percutaneous coronary interventionCynthia M Westerhout, L Duncan Saunders, Padma Kaul, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|November 6, 2014
Hospital ward design and prevention of hospital-acquired infections: A prospective clinical trialJennifer Ellison, Danielle Southern, Donna Holton, et al.
BMC Emergency Medicine|October 21, 2015
Assessing the association between occupancy and outcome in critically Ill hospitalized patients with sepsisDean W Yergens, William A Ghali, Peter D Faris, et al.
La Revue De Medecine Interne|September 3, 2003
[A common mutation C677T in the 5,10-methyltetrahydrofolate reductase gene is associated to idiopathic deep venous thrombosis]G Berrut, A Ghali, I Quere, et al.
The American Journal of Medicine|December 19, 2001
Use of chelation therapy after coronary angiographyH Quan, W A Ghali, M J Verhoef, et al.
Journal of Clinical Epidemiology|October 18, 2002
In the dark: the reporting of blinding status in randomized controlled trialsVictor M Montori, Mohit Bhandari, P J Devereaux, et al.
Thrombosis and Haemostasis|September 28, 2002
Transition from unfractionated heparin to low molecular weight heparinsWilliam A Ghali, Andre Pannatier, Ross T Tsuyuki, et al.
Journal of Wound Care|February 16, 2013
The effect of continuous pressure monitoring on strategic shifting of medical inpatients at risk for PUsS M Motamedi, J de Grood, S Harman, et al.
Critical Care (London, England)|January 1, 2015
A meta-analysis to derive literature-based benchmarks for readmission and hospital mortality after patient discharge from intensive careF Shaun Hosein, Derek J Roberts, Tanvir Chowdhury Turin, et al.
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|July 11, 2014
Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic diseaseDanielle A Southern, Jasmine Poole, Alka Patel, et al.
Pageof 45

Showing results (241-250 of 441) with videos related to

Sort By:
Pageof 45
The Canadian Journal of Cardiology|April 2, 2004
Interinstitutional variation in the use of abciximab for percutaneous coronary interventionCynthia M Westerhout, L Duncan Saunders, Padma Kaul, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|November 6, 2014
Hospital ward design and prevention of hospital-acquired infections: A prospective clinical trialJennifer Ellison, Danielle Southern, Donna Holton, et al.
BMC Emergency Medicine|October 21, 2015
Assessing the association between occupancy and outcome in critically Ill hospitalized patients with sepsisDean W Yergens, William A Ghali, Peter D Faris, et al.
La Revue De Medecine Interne|September 3, 2003
[A common mutation C677T in the 5,10-methyltetrahydrofolate reductase gene is associated to idiopathic deep venous thrombosis]G Berrut, A Ghali, I Quere, et al.
The American Journal of Medicine|December 19, 2001
Use of chelation therapy after coronary angiographyH Quan, W A Ghali, M J Verhoef, et al.
Journal of Clinical Epidemiology|October 18, 2002
In the dark: the reporting of blinding status in randomized controlled trialsVictor M Montori, Mohit Bhandari, P J Devereaux, et al.
Thrombosis and Haemostasis|September 28, 2002
Transition from unfractionated heparin to low molecular weight heparinsWilliam A Ghali, Andre Pannatier, Ross T Tsuyuki, et al.
Journal of Wound Care|February 16, 2013
The effect of continuous pressure monitoring on strategic shifting of medical inpatients at risk for PUsS M Motamedi, J de Grood, S Harman, et al.
Critical Care (London, England)|January 1, 2015
A meta-analysis to derive literature-based benchmarks for readmission and hospital mortality after patient discharge from intensive careF Shaun Hosein, Derek J Roberts, Tanvir Chowdhury Turin, et al.
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|July 11, 2014
Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic diseaseDanielle A Southern, Jasmine Poole, Alka Patel, et al.
Pageof 45